- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
US Representative Earl Blumenhauer (D-OR) is sending a letter to President Obama asking him to follow his recent comments on cannabis and its classification under federal law with action. Will you call your US Representative today and ask him or her to support this effort by signing Representative Blumenhauer’s letter?
President Obama told a reporter that cannabis was no more dangerous than alcohol on January 27. When asked about that comment by a CNN reporter a few days later, the President said it was up to Congress to decide which drugs belong on Schedule I – a classification reserved for dangerous drugs with no medical value. It is encouraging to hear the President taking a relatively enlightened view of the safety of cannabis and raising the question about its classification under federal law. But we need him to go further.
Representative Blumenhauer’s letter points out that the classification of cannabis as a dangerous drug has real human and financial costs for Americans, costs that fall disproportionately on minorities. The letter calls on the President to instruct US Attorney General Eric Holder to start the process of reclassification (called “rescheduling”) or to simply do it himself. The letter will be most effective if other US Representatives sign on, too.
You may think that making one short phone calls about a letter does not amount to much. Think again. We are seeing momentum behind medical cannabis in Washington, DC, right now. Senate Majority Leader Harry Reid responded to the President’s comment saying, “I think we need to take a real close look at this...I think that there’s some medical reasons for marijuana.” And just a short time later, US Attorney General Holder announced changes to federal banking policy concerning cannabis and medical cannabis organizations. That is more out of national leaders than we have seen in a long time!
Now we need your help to keep that momentum. The President and Attorney General need to see signatures from Members of Congress from all over the country on Blumenhauer’s letter. That means your US Representative needs to know it matters to voters in the District. Take a few minutes to make a short call – maybe as little as two minutes– and you can help make that happen.
Americans for Safe Access, the nation’s leading medical cannabis patients’ advocacy organization, is committed to changing medical cannabis law in Washington, DC. We need your participation and support to do it. Help us make the most of this strategic moment and keep fighting for medical cannabis. Make a special contribution to ASA today.